Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endocannabinoid Signaling in Autism
Bhismadev Chakrabarti, Antonio M. Persico, Natalia Battista, et al.
Neurotherapeutics (2015) Vol. 12, Iss. 4, pp. 837-847
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Plasma anandamide concentrations are lower in children with autism spectrum disorder
Debra S. Karhson, Karolina Krasinska, Jamie Ahloy‐Dallaire, et al.
Molecular Autism (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 130
Sex‐specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling
Francesca Melancia, Sara Schiavi, Michela Servadio, et al.
British Journal of Pharmacology (2018) Vol. 175, Iss. 18, pp. 3699-3712
Open Access | Times Cited: 118
Polyunsaturated fatty acids and endocannabinoids in health and disease
Hércules Rezende Freitas, Alinny Rosendo Isaac, Renato Malcher‐Lopes, et al.
Nutritional Neuroscience (2017) Vol. 21, Iss. 10, pp. 695-714
Closed Access | Times Cited: 103
Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases
Dhanush Haspula, Michelle A. Clark
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7693-7693
Open Access | Times Cited: 102
Lipidome alterations in human prefrontal cortex during development, aging, and cognitive disorders
Qianhui Yu, Zhisong He, Dmitry Zubkov, et al.
Molecular Psychiatry (2018) Vol. 25, Iss. 11, pp. 2952-2969
Open Access | Times Cited: 99
New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
Berhanu Geresu Kibret, Hiroki Ishiguro, Yasue Horiuchi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 975-975
Open Access | Times Cited: 45
Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study
Micha Hacohen, Orit Stolar, Matitiahu Berkovitch, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 44
Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind, and placebo-controlled clinical trial
Estácio Amaro da Silva Júnior, Wandersonia Moreira Brito Medeiros, João Paulo Mendes dos Santos, et al.
Trends in Psychiatry and Psychotherapy (2022)
Open Access | Times Cited: 39
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling
V.M. Doenni, Jennifer M. Gray, Chen Song, et al.
Brain Behavior and Immunity (2016) Vol. 58, pp. 237-247
Open Access | Times Cited: 71
Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes
Amos Olusegun Abioye, Oladapo Ayodele, Aleksandra Marinkovic, et al.
Journal of Cannabis Research (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 66
Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies
Laura Fusar‐Poli, Vito Cavone, Silvia Tinacci, et al.
Brain Sciences (2020) Vol. 10, Iss. 9, pp. 572-572
Open Access | Times Cited: 66
Chronic treatment with the phytocannabinoid Cannabidivarin (CBDV) rescues behavioural alterations and brain atrophy in a mouse model of Rett syndrome
Daniele Vigli, Livia Cosentino, Carla Raggi, et al.
Neuropharmacology (2018) Vol. 140, pp. 121-129
Closed Access | Times Cited: 62
Cannabis and cannabinoid use in autism spectrum disorder: a systematic review
Estácio Amaro da Silva Júnior, Wandersonia Moreira Brito Medeiros, Nelson Torro Alves, et al.
Trends in Psychiatry and Psychotherapy (2021)
Open Access | Times Cited: 54
Medicinal Cannabis for Paediatric Developmental, Behavioural and Mental Health Disorders
Daryl Efron, Kaitlyn Taylor
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 8, pp. 5430-5430
Open Access | Times Cited: 18
Endocannabinoid signaling in social functioning: an RDoC perspective
Debra S. Karhson, Antonio Y. Hardan, Karen J. Parker
Translational Psychiatry (2016) Vol. 6, Iss. 9, pp. e905-e905
Open Access | Times Cited: 53
Emerging Role of (Endo)Cannabinoids in Migraine
Pinja Leimuranta, Leonard Khiroug, Rashid Giniatullin
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 53
Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review
Lauren Rice, Lisa Cannon, Navin Dadlani, et al.
European Child & Adolescent Psychiatry (2023) Vol. 33, Iss. 2, pp. 505-526
Open Access | Times Cited: 14
Molecular Pathology and Pharmacological Treatment of Autism Spectrum Disorder-Like Phenotypes Using Rodent Models
Hsiao‐Ying Kuo, Fu‐Chin Liu
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 46
Current state of evidence of cannabis utilization for treatment of autism spectrum disorders
Rumi Agarwal, Shanna L. Burke, Marlaina Maddux
BMC Psychiatry (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 38
Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
Hiroki Ishiguro, Berhanu Geresu Kibret, Yasue Horiuchi, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 20
Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits
Patrícia Soares Silva Montagner, Wesley Medeiros, Leandro Cruz Ramires da Silva, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 11
Purified cannabidiol leads to improvement of severe treatment-resistant behavioral symptoms in children with autism spectrum disorder
Pablo Sebastián Fortini, Javier J Toibaro, Roberto Caraballo
Pharmacology Biochemistry and Behavior (2025) Vol. 249, pp. 173971-173971
Closed Access
A Systems Biology Approach for Prioritizing ASD Genes in Large or Noisy Datasets
Veronica Remori, Heather Bondi, Mario Airoldi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2078-2078
Open Access
BEHAVIORAL AND TRANSCRIPTOMIC EFFECTS OF A NOVEL CANNABINOID ON A RAT VALPROIC ACID MODEL OF AUTISM
Sally Loomis, Dylan E. Da Silva, Ranjev Savopoulos, et al.
Neuropharmacology (2025), pp. 110450-110450
Closed Access
CB1-receptor-mediated inhibitory LTD triggers presynaptic remodeling via protein synthesis and ubiquitination
Hannah R. Monday, Mathieu Bourdenx, Bryen A. Jordan, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top